Narrow search
Showing 1 - 10 of 63,858
Cover Image
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Sanchez-de la Rosa, Rainel; Sabater, Eliazar; Casado, … - In: Health Economics Review 3 (2013) 13, pp. 1-5
Background: Fingolimod is an innovative drug with a significant budget impact in the treatment of MS in Spain. The aim … of this study was to calculate the direct cost comparison of glatiramer acetate and fingolimod for the treatment of … patients with relapsing-remitting multiple sclerosis (RRMS) in Spain. Methods: A cost analysis model was developed to compare …
Persistent link: https://www.econbiz.de/10010317177
Cover Image
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Rosa, Rainel Sanchez-de la; Sabater, Eliazar; Casado, Miguel - In: Health Economics Review 3 (2013) 1, pp. 1-5
Fingolimod therapy requires twice the investment as glatiramer acetate. </AbstractSection> Copyright Sanchez-de la Rosa …
Persistent link: https://www.econbiz.de/10010998799
Cover Image
Gesundheit im Brennpunkt
Zapotoczky, Klaus; Grausgruber, Alfred; Mechtler, Reli - 1999
Persistent link: https://www.econbiz.de/10010468980
Cover Image
Gesundheit im Brennpunkt
Zapotoczky, Klaus; Grausgruber, Alfred; Mechtler, Reli - 1999
Persistent link: https://www.econbiz.de/10010468981
Cover Image
The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease
Špacírová, Zuzana; Kaptoge, Stephen; … - In: The European journal of health economics 24 (2023) 7, pp. 1033-1045
Persistent link: https://www.econbiz.de/10014328169
Cover Image
Sustainable development goal halftime project : benefit-cost analysis using methods from the decade of vaccine economics model
Patenaude, Bryan N.; Sriudomporn, Salin; Mak, Joshua - In: Journal of benefit-cost analysis : JBCA 14 (2023), pp. 136-180
Persistent link: https://www.econbiz.de/10015055372
Cover Image
Direct-to-consumer advertising and the role of hope
Delbaere, Majorie; Willis, Erin - In: Journal of medical marketing : device, diagnostic and … 15 (2015) 1/2, pp. 26-38
Persistent link: https://www.econbiz.de/10011618114
Cover Image
Best investments in chronic, noncommunicable disease prevention and control in low- and lower-middle-income countries
Watkins, David; Ahmed, Sali; Pickersgill, Sarah - In: Journal of benefit-cost analysis : JBCA 14 (2023), pp. 255-271
Persistent link: https://www.econbiz.de/10015055373
Cover Image
Ageing, chronic conditions and the evolution of future drugs expenditure : a five-year micro-simulation from 2004 to 2029
Thiébaut, Sophie P.; Barnay, T.; Ventelou, Bruno - In: Applied economics 45 (2013) 13/15, pp. 1663-1672
Persistent link: https://www.econbiz.de/10009758548
Cover Image
The economic benefits of pharmaceutical innovations : the case of Cox-2 inhibitors
Garthwaite, Craig L. - In: American economic journal : a journal of the American … 4 (2012) 3, pp. 116-137
Persistent link: https://www.econbiz.de/10009582520